LUNG SQUAMOUS CELL CARCINOMA
Clinical trials for LUNG SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LUNG SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for LUNG SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cocktail attack for inoperable lung cancer shows promise
Disease control OngoingThis study tested a three-part treatment for people with stage III non-small cell lung cancer that cannot be removed by surgery. The treatment combined standard chemotherapy (cisplatin, etoposide, docetaxel) and radiation with a drug called bevacizumab, which blocks blood flow to…
Matched conditions: LUNG SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 17, 2026 02:41 UTC
-
Could a new drug combo shrink tough lung tumors?
Disease control OngoingThis study tests whether adding the drug veliparib to standard chemotherapy and radiation helps people with stage III lung cancer that can't be removed by surgery. About 53 adults took part to find the best dose and see if the combination slows cancer growth. The goal is to impro…
Matched conditions: LUNG SQUAMOUS CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 15, 2026 19:08 UTC
-
Scientists hunt for clues to predict immunotherapy success in common cancers
Knowledge-focused OngoingThis study aims to find biological markers that can predict whether a patient with squamous cell carcinoma (of the esophagus, cervix, lung, or head and neck) will respond to treatment with PD-1 inhibitors, a type of immunotherapy. Researchers will analyze blood and tumor tissue s…
Matched conditions: LUNG SQUAMOUS CELL CARCINOMA
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:56 UTC